Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT00655018

Effect of Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) (VITENAFLD)

Lifestyle Intervention and Antioxidants in Children With Nonalcoholic Fatty Liver Disease: A Randomized, Controlled Trial

Sponsor: Bambino Gesù Hospital and Research Institute

Conditions Fibrosis Inflammation Insulin Resistance

Interventions Placebo Vitamin treatment (alpha tocopherol plus ascorbic acid)

Updated 5 times since 2017 Last updated: Apr 8, 2008 Started: Jan 31, 2003 Primary completion: Oct 31, 2006 Completion: Oct 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Fibrosis and Inflammation, this trial is completed. The trial is conducted by Bambino Gesù Hospital and Research Institute and has accumulated 5 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Jan 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bambino Gesù Hospital and Research Institute

Data source: Bambino Gesù Hospital and Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rome, Italy